| 1 | Prescribing, dispensing, and administering extended-release (ER) opioids to opioid-naïve patients |
| 2 | Not using smart infusion pumps with dose error-reduction systems (DERS) in perioperative settings |
| 3 | Errors with oxytocin |
| 4 | Hazards associated with positioning infusion pumps outside of COVID-19 patients’ rooms |
| 5 | Errors with the COVID-19 vaccines |
| 6 | Use of the retrospective, proxy “syringe pull-back” method of verification during pharmacy sterile compounding |
| 7 | Combining or manipulating commercially available sterile products outside the pharmacy |
| 8 | Medication loss in the tubing when administering small-volume infusions via a primary administration set |
| 9 | Wrong route (intraspinal injection) errors with tranexamic acid |
| 10 | Use of error-prone abbreviations, symbols, or dose designations |
To read the whole article, click the link below: